The “Radiopharma at Reflection Point: Bridging the Chain, Forging a high-quality Future” Innovation Salon, co-hosted by Asymchem and Healthcare Executive, was concluded successfully.

The event brought together representatives from leading multinational pharmaceutical companies, including AstraZeneca and Bayer, as well as prominent domestic radiopharmaceutical innovators such as New Ruite, NanAn Biotech, Jinghe Biotech, and Yili Pharma.

In addition, experts from leading research institutes across China and representatives from top investment firms specializing in the healthcare and pharmaceutical sectors participated in the forum.

Attendees engaged in in-depth discussions across multiple dimensions, including cutting-edge scientific research, technological innovation, industrial collaboration, and capital-driven development. The forum focused on key topics spanning the radiopharmaceutical development lifecycle, including preclinical research, clinical development, CMC process development, manufacturing, and quality control, while exploring strategies for accelerating innovation through an integrated, end-to-end development approach.

By fostering radiopharmaceutical innovation and strengthening industry-wide collaboration, the event helped connect key resources across the value chain and support the high-quality development of the radiopharmaceutical sector.